MAP Pharmaceuticals, Inc. (MAPP) Tops Q2 EPS by 10c
Tweet
Share
E-mailGet Alerts MAPP Hot Sheet
Price: $28.29 -0.04%
Financial Fact:
Income (loss) from operations: -12.62M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Financial Fact:
Income (loss) from operations: -12.62M
Today's EPS Names:
SVBT, ZEO, OTLK, More
Join SI Premium – FREE
MAP Pharmaceuticals, Inc. (NASDAQ: MAPP) reported Q2 loss of ($0.28), $0.10 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $2.55 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
- Neumora Therapeutics, Inc. (NMRA) Tops Q2 EPS by 4c
- SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
